Answers are grounded in this paper and cite their sources.
Sumatriptan is a selective agonist of 5-hydroxytryptamine receptors, recommended for the acute treatment of migraine. The 5-HT1 receptor subtype is found in the cranial vasculature of many species including humans, and causes vasoconstriction of these vessels. Sumatriptan as a highly potent 5-HT1 agonist selectively constricts large intracranial blood vessels and also blocks neurogenic inflammation. Those treating patients with severe or inconveniently timed attacks will find sumatriptan the drug of choice.
No takes yet. Share an insight, caveat, or question.
Michael L. Gross (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: